The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 13, 2025
Filed:
Dec. 02, 2022
Applicant:
The Schepens Eye Research Institute, Inc., Boston, MA (US);
Inventors:
Dong Feng Chen, Newtonville, MA (US);
Chenying Guo, Malden, MA (US);
Assignee:
The Schepens Eye Research Institute, Inc., Boston, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/18 (2006.01); A61K 31/00 (2006.01); A61K 31/352 (2006.01); A61K 31/7004 (2006.01); A61K 31/708 (2006.01); A61K 31/7088 (2006.01); A61K 31/7105 (2006.01); A61K 31/711 (2006.01); A61K 31/713 (2006.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61K 38/19 (2006.01); A61K 38/20 (2006.01); A61K 38/21 (2006.01); A61K 38/22 (2006.01); A61K 38/30 (2006.01); A61K 45/06 (2006.01); C07K 14/00 (2006.01); C07K 14/47 (2006.01); C07K 14/48 (2006.01); A61K 9/00 (2006.01); A61K 9/51 (2006.01); A61K 35/30 (2015.01); A61K 48/00 (2006.01); A61K 49/00 (2006.01); C12N 5/079 (2010.01); C12N 5/0797 (2010.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
A61K 38/18 (2013.01); A61K 31/00 (2013.01); A61K 31/352 (2013.01); A61K 31/7004 (2013.01); A61K 31/708 (2013.01); A61K 31/7088 (2013.01); A61K 31/7105 (2013.01); A61K 31/711 (2013.01); A61K 31/713 (2013.01); A61K 38/1738 (2013.01); A61K 38/1841 (2013.01); A61K 38/2278 (2013.01); A61K 38/30 (2013.01); A61K 45/06 (2013.01); A61K 9/0019 (2013.01); A61K 9/0048 (2013.01); A61K 9/0085 (2013.01); A61K 9/5169 (2013.01); A61K 35/30 (2013.01); A61K 38/1703 (2013.01); A61K 38/1709 (2013.01); A61K 38/22 (2013.01); A61K 48/00 (2013.01); A61K 49/0056 (2013.01); A61K 2300/00 (2013.01); C12N 5/0621 (2013.01); C12N 5/0623 (2013.01); C12N 2501/105 (2013.01); C12N 2502/08 (2013.01); C12N 2502/081 (2013.01); C12N 2533/50 (2013.01); G01N 33/5058 (2013.01); G01N 33/5073 (2013.01); Y02A 50/30 (2018.01);
Abstract
Disclosed is a method of promoting neuronal growth by administering IGFBPL-1, or an agent that increases or stabilizes IGFBPL-1 activity to a subject in need thereof, e.g., a subject in need of treating optic nerve degeneration.
Chen, Dong. (2025). Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (igfbpl1) (U.S. Patent No. 12295985). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12295985
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile